Highlights the severe risks of general anaesthesia in patients with Adriamycin-induced cardiomyopathy and emphasizes the need for careful anaesthetic management due to the insidious onset of cardiac impairment.
Answers are grounded in this paper and cite their sources.
Anaesthetic death in paediatric Adriamycin cardiomyopathy signals high perioperative risk; leaves open evidence-based management strategies.
The death under general anaesthesia of a child with Adriamycin cardiomyopathy is reported. The acute, subacute and chronic cardiotoxic effects of Adriamycin are discussed and the risk factors for chronic Adriamycin cardiomyopathy presented, with particular reference to cumulative dosage of Adriamycin. The insidious onset of impairment of cardiac function is stressed and suggestions for anaesthetic management outlined.
No takes yet. Share an insight, caveat, or question.
McQuillan et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: